Right ventricular function and right-heart echocardiographic response to therapy predict long-term outcome in patients with pulmonary hypertension

Canadian Journal of Cardiology

Volumn 31, Issue 4, 2015, Pages 529-536

  Sano, Hiroyuki ^a   Tanaka, Hidekazu ^a   Motoji, Yoshiki ^a   Fukuda, Yuko ^a   Sawa, Takuma ^a   Mochizuki, Yasuhide ^a   Ryo, Keiko ^a   Matsumoto, Kensuke ^a   Emoto, Noriaki ^a   Hirata, Ken ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CARDIAC PATIENT; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEMODYNAMIC PARAMETERS; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRASOUND TRANSDUCER; AGED; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ENDARTERECTOMY; ETIOLOGY; FOLLOW UP; HEART VENTRICLE; HYPERTENSION, PULMONARY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; TIME;

AGED; ANTIHYPERTENSIVE AGENTS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENDARTERECTOMY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84926019606     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.01.027     Document Type: Article

References (21)

1. Humbert M., Sitbon O., Simonneau G. Treatment of pulmonary arterial hypertension. NEngl J Med 2004, 351:1425-1436.
2. Voelkel N.F., Quaife R.A., Leinwand L.A., et al. Right ventricular function and failure: report of a national heart, lung, and blood institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114:1883-1891.
3. McLaughlin V.V., McGoon M.D. Pulmonary arterial hypertension. Circulation 2006, 114:1417-1431.
4. Galie N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
5. Forfia P.R., Fisher M.R., Mathai S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006, 174:1034-1041.
6. Ghio S., Klersy C., Magrini G., et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010, 140:272-278.
7. Fine N.M., Chen L., Bastiansen P.M., et al. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging 2013, 6:711-721.
8. Fukuda Y., Tanaka H., Motoji Y., et al. Utility of combining assessment of right ventricular function and right atrial remodeling as a prognostic factor for patients with pulmonary hypertension. Int J Cardiovasc Imaging 2014, 30:1269-1277.
9. Haeck M.L., Scherptong R.W., Marsan N.A., et al. Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging 2012, 5:628-636.
10. Motoji Y., Tanaka H., Fukuda Y., et al. Efficacy of right ventricular free-wall longitudinal speckle-tracking strain for predicting long-term outcome in patients with pulmonary hypertension. Circ J 2013, 77:756-763.
11. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. JAm Soc Echocardiogr 2010, 23:685-713. [quiz 86-8].
12. Rai P.R., Cool C.D., King J.A., et al. The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:558-564.
13. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr 2005, 18:1440-1463.
14. Chin K.M., Kim N.H., Rubin L.J. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005, 16:13-18.
15. Bustamante-Labarta M., Perrone S., De La Fuente R.L., et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. JAm Soc Echocardiogr 2002, 15:1160-1164.
16. Raymond R.J., Hinderliter A.L., Willis P.W., et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. JAm Coll Cardiol 2002, 39:1214-1219.
17. Fukui S., Ogo T., Morita Y., et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014, 43:1394-1402.
18. Iino M., Dymarkowski S., Chaothawee L., et al. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008, 18:792-799.
19. Guazzi M., Vicenzi M., Arena R., et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011, 124:164-174.
20. Han M.K., Bach D.S., Hagan P.G., et al. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest 2013, 143:1699-1708.
21. Chin K.M., Kingman M., de Lemos J.A., et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol 2008, 101:1669-1672.